Clinical Trial

Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics

Recruiting
View on ClinicalTrials.gov →
Summary
the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments. Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-01-13.
Trial Details
NCT Number NCT04711551
Lead Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions Musculoskeletal System Disease
Enrollment 2,000 participants
Start Date 2018-05-30
Primary Completion 2030-05-30 (estimated)
Study Completion 2030-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-17